Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand
- PMID: 1833816
- DOI: 10.1126/science.1833816
Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand
Abstract
In the presence of antigen presenting cells, a murine T helper (Th) cell specific for murine hemoglobin (Hb) responded to its immunogenic peptide by both cytokine (interleukin-4) secretion and proliferation. An altered Hb peptide with a single amino acid substitution induced only cytokine secretion and did not induce proliferation. Interleukin-1 costimulated and restored the Th proliferative response to normal levels. The altered peptide also supported cognate T cell-B cell interactions indicative of T cell helper function. Thus, this result suggests that the T cell receptor has the capacity of differential signaling.
Similar articles
-
Separation of T helper 1 clone cytolysis from proliferation and lymphokine production using analog peptides.J Immunol. 1993 Apr 15;150(8 Pt 1):3131-40. J Immunol. 1993. PMID: 8468461
-
Pillars article: separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand. Science. 1991. 252: 1308-1310.J Immunol. 2011 Jan 1;186(1):9-12. J Immunol. 2011. PMID: 21172873 No abstract available.
-
Complete dissection of the Hb(64-76) determinant using T helper 1, T helper 2 clones, and T cell hybridomas.J Immunol. 1992 Jan 15;148(2):347-53. J Immunol. 1992. PMID: 1370311
-
Dissection of the Hb(64-76) determinant reveals that the T cell receptor may have the capacity to differentially signal.Adv Exp Med Biol. 1992;323:17-21. doi: 10.1007/978-1-4615-3396-2_3. Adv Exp Med Biol. 1992. PMID: 1485563 Review. No abstract available.
-
Modification of human T-cell responses by altered peptide ligands: a new approach to antigen-specific modification.Intern Med. 1998 Oct;37(10):804-17. doi: 10.2169/internalmedicine.37.804. Intern Med. 1998. PMID: 9840700 Review.
Cited by
-
Antigen-specific therapeutic approaches in Type 1 diabetes.Cold Spring Harb Perspect Med. 2012 Feb;2(2):a007773. doi: 10.1101/cshperspect.a007773. Cold Spring Harb Perspect Med. 2012. PMID: 22355799 Free PMC article. Review.
-
PD-1 or PD-L1 Blockade Restores Antitumor Efficacy Following SSX2 Epitope-Modified DNA Vaccine Immunization.Cancer Immunol Res. 2015 Aug;3(8):946-55. doi: 10.1158/2326-6066.CIR-14-0206. Epub 2015 Jun 3. Cancer Immunol Res. 2015. PMID: 26041735 Free PMC article.
-
Use of TIRF to Monitor T-Lymphocyte Membrane Dynamics with Submicrometer and Subsecond Resolution.Cell Mol Bioeng. 2015;8(1):178-186. doi: 10.1007/s12195-014-0361-8. Epub 2014 Oct 22. Cell Mol Bioeng. 2015. PMID: 25798205 Free PMC article.
-
Different growth factor requirements for human Th2 cells may reflect in vivo induced anergy.Clin Exp Immunol. 1994 Oct;98(1):151-7. doi: 10.1111/j.1365-2249.1994.tb06622.x. Clin Exp Immunol. 1994. PMID: 7923875 Free PMC article.
-
Class I major histocompatibility complex-restricted cytotoxic T lymphocytes specific for Epstein-Barr virus (EBV)-transformed B lymphoblastoid cell lines against which they were raised.J Exp Med. 1995 Jun 1;181(6):2221-8. doi: 10.1084/jem.181.6.2221. J Exp Med. 1995. PMID: 7539044 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources